Table 1.
Complete patient data
| Patient | Age | Gender | Followup (months) | Tumor | Site | Pain | Erode | Recurrence | MSTS Complications | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 46 | F | Clinic, 134 | C | Humerus | Yes | Yes | – | 29 | – |
| 2 | 40 | M | Clinic, 117 | C/E | Femur | Yes | Yes | – | 11 | – |
| 3 | 54 | F | Clinic, 113 | E | Humerus | Yes | Yes | – | 30 | Postoperative fracture |
| 4 | 38 | F | Clinic, 113 | C/E | Tibia | Yes | Yes | – | 30 | – |
| 5 | 63 | F | Clinic, 88 | C | Tibia | Yes | Yes | – | 30 | – |
| 6 | 71 | M | Clinic, 80 | C/E | Humerus | No | Yes | – | 30 | – |
| 7 | 73 | F | Clinic, 75 | C/E | Femur | Yes | Yes | – | 30 | – |
| 8 | 49 | M | Clinic, 61 | C/E | Tibia | Yes | Yes | – | 29 | – |
| 9 | 37 | M | Clinic, 54 | C | Femur | Yes | Yes | Yes* | 26 | Postoperative fracture |
| 10 | 71 | F | Clinic, 54 | C/E | Humerus | Yes | Yes | – | 30 | – |
| 11 | 58 | F | Clinic, 52 | E | Humerus | Yes | No | – | 30 | – |
| 12 | 53 | F | Clinic, 50 | C/E | Humerus | Yes | Yes | – | 29 | – |
| 13 | 49 | M | Clinic, 48 | C | Humerus | Yes | Yes | Yes* | 29 | Leftover tumor |
| 14 | 49 | M | Clinic, 48 | E | Tibia | Yes | No | – | 25 | – |
| 15 | 39 | F | Clinic, 46 | C | Humerus | Yes | Yes | – | 27 | – |
| 16 | 42 | F | Clinic, 45 | C/E | Humerus | Yes | Yes | – | 30 | – |
| 17 | 70 | F | Clinic, 42 | C | Fibula | Yes | Yes | – | 30 | – |
| 18 | 43 | M | Clinic, 37 | C | Humerus | Yes | Yes | – | 28 | – |
| 19 | 46 | F | Clinic, 36 | E | Femur | Yes | Yes | – | 30 | – |
| 20 | 44 | F | Clinic, 35 | C | Femur | No | Yes | – | 30 | – |
| 21 | 45 | F | Clinic, 34 | C | Humerus | Yes | Yes | – | 29 | – |
| 22 | 64 | M | Clinic, 33 | C | Femur | Yes | Yes | – | 30 | – |
| 23 | 45 | F | Clinic, 29 | C | Humerus | Yes | Yes | – | 16 | – |
| 24 | 58 | M | Clinic, 26 | E | Humerus | Yes | Yes | – | 30 | – |
| 25 | 52 | F | Clinic, 23 | E | Femur | Yes | No | – | 30 | – |
| 26 | 18 | M | Clinic, 23 | C | Tibia | Yes | Yes | – | 20 | – |
| 27 | 50 | F | Clinic, 20 | C | Femur | Yes | Yes | – | 29 | – |
| 28 | 45 | F | Clinic, 18 | E | Fibula | Yes | Yes | – | 14 | – |
| 29 | 52 | M | Clinic, 18 | C/E | Humerus | Yes | Yes | – | 29 | – |
| 30 | 35 | M | Clinic, 18 | C | Metatarsal | Yes | Yes | – | 29 | – |
| 31 | 40 | F | Clinic, 18 | C | Humerus | Yes | Yes | – | 30 | – |
| 32 | 46 | F | Clinic, 18 | E | Radius | Yes | Yes | – | 28 | – |
| 33 | 43 | F | Phone, 67 | E | Metatarsal | Yes | No | – | 30 | – |
| 34 | 49 | M | Phone, 66 | E | Humerus | Yes | No | – | 26 | – |
| 35 | 41 | F | Phone, 59 | C/E | Femur | Yes | No | – | 25 | – |
| 36 | 77 | F | Phone, 54 | E | Femur | Yes | Yes | – | 23 | – |
| 37 | 24 | F | Phone, 53 | E | Femur | Yes | Yes | – | 30 | – |
| 38 | 31 | F | Phone, 32 | E | Ischium | Yes | Yes | – | 30 | – |
| 39 | 42 | M | Phone, 18 | E | Humerus | Yes | Yes | – | 19 | – |
| 40 | 20 | F | Clinic, 53 | E | Femur | Yes | No | – | – | – |
| 41 | 49 | F | Clinic, 32 | C/E | Humerus | Yes | Yes | – | – | – |
| 42 | 56 | F | Clinic, 32 | E | Humerus | Yes | No | – | – | Postoperative fracture |
| 43 | 41 | F | Clinic, 29 | C | Sacrum | Yes | Yes | – | – | – |
| 44 | 53 | F | Clinic, 28 | C/E | Humerus | Yes | Yes | – | – | – |
| 45 | 40 | M | Clinic, 25 | C | Ilium | Yes | No | – | – | – |
| 46 | 60 | M | Clinic, 18 | C/E | Humerus | Yes | No | – | – | – |
Age = in years at date of initial surgery; Followup = by clinic or phone interview in months since initial surgery; MSTS = Musculoskeletal Tumor Society functional score out of 30 points; Site = anatomic location of tumor; Pain = signs of preoperative pain; Erode = radiographic evidence of endosteal scalloping or cortical erosion; * both cases of recurrence detected 18 months after initial surgery; Complications = postoperative fracture, leftover tumor from incomplete removal; F = female; M = male; C = chondrosarcoma Grade 1; E = enchondroma; C/E = chondrosarcoma Grade 1 or enchondroma.